Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical or safety concerns.

UNCY $110M
Triple S Special Situations Investing 4 clicks

From X

@StableBread

Fajasy on X

Q2 2026 was the first quarter of positive FCF at Magna Mining $MGMNF (TSX: $NICU), but only because cash from March sales arrived in April. The quarter set Magna-era records for revenue and cash margin: → Revenue: US$21.5M, after the precious metals stream and higher smelting and refining charges. → Cash margin: Record US$6.4M, or US$1.41/payable lb, up from US$4.3M in Q1. → Operating cash flow: US$6.4M, including US$4.8M of March sales paid in April. → Free cash flow: US$3.7M, even though operating cash flow absorbed US$3.8M of exploration and evaluation spending, mostly at Levack, Magna’s flagship restart project. Adjusted for the US$4.8M of March sales paid in April, Q2 FCF was an outflow of ~US$1.2M, and H1 2026 as a whole was a US$10.5M outflow. At the mine level, McCreedy West (Magna’s producing mine) generated a US$10.8M cash margin in H1 2026, covering its US$3.6M of sustaining capital almost three times over. But Levack, corporate costs, interest, and working capital kept the company as a whole cash-negative. As of June 30, 2026, Magna held US$28.2M of cash. With net proceeds from Alpayana, the Peruvian mining group that bought 19.9% in August, the September deck puts cash at ~US$124M. Magna’s only debt is US$16.9M of unsecured 10% convertible notes due March 5, 2029, a third of which Dundee Corporation $DDEJF, a Toronto investment company, bought. They convert at CAD$2.00/share into 11.98M shares, or 3.8% of the current share count. Magna has funded itself mostly with equity, so the share count rose from 163.4M at the end of 2023 to 313.35M after Alpayana, up 91.8%. Options and share units add more. At June 30, Magna had 12.35M options at a weighted average exercise price of CAD$1.21 and 1.73M restricted and deferred share units. At CAD$2.45, 9.64M of the options are in the money, and exercising them would give Magna ~US$5.1M of cash. Counting the in-the-money options, the share units, and the notes, the diluted count is 336.70M (313.35M + 9.64M + 1.73M + 11.98M).
@BrokenMoats 2 clicks

Broken Moats on X

$DNA another perfectly rational move, happens daily across this low quality business, low quality balance sheet biotech tangential name space (ironically while actual biotech names sell off due to rates). My biggest question is why are these co. not raising $$$, all of them need money in this basket and their stock prices are up 100's% points in a very short period of time (few months). Wh not stretch the life of the company and fix the balance sheets?
@StableBread

Fajasy on X

Half the gold, platinum, and palladium in ore from McCreedy West, the producing mine of Magna Mining $MGMNF (TSX: $NICU), goes to Franco-Nevada $FNV for $1,200 per gold-equivalent ounce, 29.0% of the average gold price in Q4 2025. Magna inherited the deal, a precious metals stream, when it bought McCreedy West from KGHM $KGHPF, the Polish copper giant. A stream is a deal where a financier pays a miner upfront for the right to buy part of its future metal at a discount to market. Magna’s stream gives Franco-Nevada 50% of the gold, platinum, and palladium in ore from McCreedy West and “certain areas” of Levack and Podolsky, until the deposits run out or 2048. Franco-Nevada pays 60% of the monthly average gold price per gold-equivalent ounce (platinum and palladium converted into gold) from McCreedy West, capped at $1,200/oz once gold tops $2,000. In Q2 2026, the stream cut net revenue by US$3.9M, so revenue would have been ~18% higher without the stream. CEO Jason Jessup called the stream “a bit of an overhang” on McCreedy West, and in April said its terms are “definitely open for discussion” with Franco-Nevada. The higher gold climbs, the more the stream costs Magna, and I wouldn’t count on Franco-Nevada softening the terms. Crean Hill, Magna’s permitted nickel mine, carries no Franco-Nevada stream, and Jessup says R2, the high-grade zone Magna found at its flagship Levack mine, has none either. At Q4 2025’s gold price, Magna kept 64.5% of the value of McCreedy West’s gold, platinum, and palladium (50% + 50% × 29.0%). That means a stream-free ounce from Crean Hill or R2 is worth 1.55x as much to Magna as one from McCreedy West (100% / 64.5%). The stream also covers two areas of Levack, including the Morrison deposit. Franco-Nevada’s filings set the price for its Sudbury streams at $400/oz, rising 1% a year from July 2011, and its later increases applied to McCreedy West only, so Levack’s price would’ve reached ~$460/oz by Q4 2025 ($400 × 1.01^14). So at Q4 2025’s gold price, Magna would keep 55.6% of the value of Levack’s streamed ounces (50% + 50% × ($460 / $4,141.90)), less than the 64.5% it kept at McCreedy West.

Investor Letters

All letters

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M
Calvin Blissett 10 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $492M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $303M
TSOH Investment Research 18 clicks

Twenty Years in the Dark

Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…

TPRP $128M
Orphan REITs 5 clicks

TSOH Weekly Roundup (10/16/2026)

Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.

BMBL $783M
TSOH Investment Research 12 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $110M
Value Investors Club

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 55 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.